Skip to main content
All blogsPeptide Guide

NAD+ Injection: The Complete Guide to the Longevity Molecule

Hollywood's most talked-about anti-aging treatment used to require a $1,000 IV drip and four hours in a clinic. The same molecule, discovered in 1906, studied by Harvard, and endorsed by half the celebrity A-list, now comes as a simple at-home injection. Here's what NAD+ actually does, why your levels are dropping every year, and whether the hype is justified.

PeRx Medical Team19 min readUpdated February 25, 2026
Saccharomyces cerevisiae (brewer's yeast) under scanning electron microscopy. In 1906, Arthur Harden and William Young discovered NAD+ while studying how these cells ferment sugar. That work contributed to a Nobel Prize. The molecule they found is now Hollywood's most expensive anti-aging treatment.
Saccharomyces cerevisiae (brewer's yeast) under scanning electron microscopy. In 1906, Arthur Harden and William Young discovered NAD+ while studying how these cells ferment sugar. That work contributed to a Nobel Prize. The molecule they found is now Hollywood's most expensive anti-aging treatment.

Key Takeaways

  • NAD+ is a coenzyme present in every cell, essential for 500+ enzymatic reactions including DNA repair, energy production, and sirtuin activation.
  • NAD+ levels decline roughly 50% between ages 40 and 60, contributing to aging, fatigue, and cognitive decline.
  • Subcutaneous NAD+ injection bypasses the digestive system for higher bioavailability than oral supplements.
  • Benefits include increased cellular energy, improved mental clarity, enhanced recovery, and longevity support.
  • PeRx prescribes NAD+ at $299/month via subcutaneous injection, shipped ready to use.

Quick Facts

Full Name

Nicotinamide Adenine Dinucleotide

First Discovered

1906 (Harden & Young)

Role in Body

400+ biological reactions

Age-Related Decline

~50% reduction by middle age

Delivery Method

Subcutaneous injection (bypasses digestion)

FDA Status

Compounded (not FDA-approved)

What NAD+ Actually Is

NAD+ is not new. It's not a Silicon Valley invention or a biohacker's pet project. Nicotinamide adenine dinucleotide was first identified in 1906 by British biochemists Arthur Harden and William Young while studying fermentation, work that would eventually contribute to a Nobel Prize. For over a century, it was known primarily as a coenzyme involved in metabolic reactions: important, but not exactly headline material.

That changed when scientists began to understand not just what NAD+ does, but what happens when you run out of it.

The molecule you can't live without

NAD+ is present in every living cell in your body and participates in over 400 biological reactions. Without it, you would die within seconds. It has two critical roles. The first is energy production: NAD+ is essential for mitochondria to convert the food you eat into ATP, the cell's energy currency. Every muscle contraction, every synapse fired, every heartbeat depends on NAD+ to generate the energy that makes it possible.

The second role is cellular repair. NAD+ is the fuel that powers two of the most important families of repair enzymes in your body: sirtuins and PARPs. Sirtuins (sometimes called "longevity genes") are a group of seven proteins that regulate DNA repair, inflammation, circadian rhythms, and metabolic function. They've been at the center of aging research for over two decades. PARPs (poly ADP-ribose polymerases) are enzymes that detect and repair DNA damage in real time. Both require NAD+ to function. No NAD+, no repair.

The decline that drives aging

Here's where it gets personal. NAD+ levels don't stay constant throughout your life. They decline significantly, measurably, and relentlessly. Research suggests that by middle age, your NAD+ levels may have dropped by roughly 50% compared to your twenties. Some estimates suggest even steeper declines in metabolically stressed tissues like the brain, heart, and muscles.

The decline is driven by a vicious feedback loop. As you age, an enzyme called CD38 (identified by researcher Eric Verdin) becomes more active and starts consuming NAD+ at an accelerating rate. Simultaneously, your body's ability to produce new NAD+ diminishes. You're making less and burning through more. And because NAD+ is required for DNA repair, less NAD+ means more unrepaired DNA damage, which activates more PARPs, which consume more NAD+, which leaves even less available for sirtuins and energy production. It's a downward spiral that tracks closely with the symptoms most people associate with getting older: fatigue, brain fog, slower recovery, metabolic dysfunction, and declining physical performance.

David Sinclair, a professor of genetics at Harvard Medical School and one of the most prominent aging researchers in the world, has described this dynamic plainly: as you get older, you're losing the ability to make NAD+, and you're also chewing it up. His lab was the first to identify a role for NAD+ biosynthesis in the regulation of lifespan, and his work on sirtuins has been central to modern longevity science.

This chart shows real human blood NAD+ data from over 1,500 people, split by sex and age group. Panel A (males) shows a steady downward trajectory: men lose NAD+ consistently as they age, with the steepest drop after 60. Panel B (females) is a surprise. Women's NAD+ levels remain relatively stable across age groups, without the pronounced decline seen in men. The dots represent average NAD+ concentration for each age bracket, with error bars showing the spread. This is one of the largest human datasets directly measuring blood NAD+, and it tells a clear story: age-related NAD+ decline is real, it's measurable, and it appears to affect men more dramatically than women.

Figure 3: NAD+ concentration trends by age group and sex, measured in whole blood from N=1,518 human subjects.

Yang F et al. (2022) Association of Human Whole Blood NAD+ Contents With Aging. Front Endocrinol 13:829658. · CC BY 4.0

Click image to zoom

NAD+ and MOTS-c: The Mitochondrial Connection

If you've read our MOTS-c guide, you'll recognize a connection. MOTS-c has been shown to increase intracellular NAD+ levels, and its effects are partly mediated through SIRT1. NAD+ and MOTS-c operate on related but distinct pathways within the same mitochondrial energy system. MOTS-c activates AMPK from the mitochondrial side; NAD+ fuels sirtuins on the repair and longevity side. Together, they represent two angles of attack on age-related metabolic decline.

Why Everyone From Hollywood to Harvard Cares

NAD+ therapy exists at a rare intersection: serious academic science and mainstream celebrity culture. Both worlds have converged on the same molecule, for overlapping but different reasons.

The Hollywood moment

The cultural tipping point came in 2022. On an episode of The Kardashians, cameras captured Hailey Bieber and Kendall Jenner sitting side by side in a clinic, IV lines running into their arms, receiving NAD+ infusions. Bieber's offhand comment became the defining quote of the NAD+ movement.

"I'm going to NAD for the rest of my life, and I'm never going to age.", Hailey Bieber, The Kardashians, 2022

Jenner, who has been open about her health anxiety, described the IV therapy as comforting, a physical reset after the stress of COVID recovery and an intense work schedule. The episode introduced millions of viewers to a molecule most had never heard of.

But Bieber and Jenner weren't the first. Jennifer Aniston told The Wall Street Journal she receives weekly NAD+ IV treatments, calling it "the future." Gwyneth Paltrow described her NAD+ drips as an anti-aging beauty treatment in Harper's Bazaar. Justin Bieber, dealing with Lyme disease and chronic fatigue, showed himself receiving IV NAD+ therapy in his documentary series Seasons. Joe Rogan has discussed NAD+ extensively on his podcast. Shannon Sharpe has incorporated NAD+ precursors into his fitness regimen. Kathy Hilton went down what she called the "NAD+ rabbit hole" and hasn't looked back.

The pattern is consistent: celebrities who can afford any treatment available are choosing NAD+ therapy. That's not proof that it works (celebrity endorsement is not clinical evidence), but it reflects a cultural signal worth understanding.

The accessibility problem

There's a catch. The NAD+ therapy that celebrities receive is IV infusion: a needle in the arm, 2-4 hours in a clinic, and a price tag of $500-1,500 per session. Most protocols call for multiple sessions per month. At that rate, NAD+ IV therapy is a five-figure annual commitment, accessible to people with celebrity budgets but financially unrealistic for most.

This is the context in which subcutaneous NAD+ injection matters. It's not a different molecule. It's the same NAD+, delivered via a simple at-home injection instead of an IV line, daily instead of periodically, and at a fraction of the cost. The injectable is, in essence, the democratization of what Hollywood has been doing for years.

The Harvard research

Behind the celebrity headlines, the science has been building for over two decades. David Sinclair's lab at Harvard has published extensively on NAD+'s role in aging, showing that restoring NAD+ levels in aged mice can reverse age-related physiological decline and restore metabolic function to youthful levels. Sinclair's personal protocol includes daily NMN (a NAD+ precursor), and his work has catalyzed an entire field of longevity research focused on NAD+ restoration.

It's worth noting, in the interest of full transparency, that the NAD+ longevity field is not without controversy. Charles Brenner, a researcher at City of Hope National Medical Center who helped popularize nicotinamide riboside (NR), has publicly challenged some of Sinclair's claims about sirtuins and resveratrol. Sinclair co-founded Metro Biotech (focused on NMN) and was involved in regulatory actions that removed NMN from the supplement market. Both researchers have financial ties to NAD+-related companies. The science is promising and actively evolving, but it's not settled, and the commercial interests of key researchers should be understood by anyone evaluating the evidence.

1906

NAD+ Discovered

Harden & Young identify NAD+ while studying fermentation. The work contributes to a Nobel Prize.

2013

NMN Reverses Aging in Mice

Sinclair shows NMN restores NAD+ and reverses age-related decline in aged mice.

2022

Cultural Tipping Point

Bieber/Jenner NAD+ IV scene on The Kardashians introduces the molecule to millions.

2000s

Sirtuin Revolution

Sinclair's lab links NAD+ to sirtuin activation and lifespan regulation in yeast and mice.

2022

Human Clinical Trials

Multiple RCTs confirm oral NMN raises blood NAD+ levels in healthy middle-aged adults.

How the Injection Works

Subcutaneous injection is one of the most efficient drug delivery methods available. The medication is deposited just beneath the skin into the fatty tissue layer, where it absorbs directly into the bloodstream without passing through the digestive system. Subcutaneous delivery is well-established in medicine: insulin, blood thinners, growth hormone, and many peptide therapies all use the same route. NAD+ injection applies this proven delivery method to the longevity molecule.

Subcutaneous NAD+ injection delivers the molecule directly into the body. The advantages over other delivery methods are significant: no digestive degradation (unlike oral supplements), no clinic appointment required (unlike IV), no conversion step needed (unlike NMN or NR, which must be enzymatically converted into NAD+ by your cells), and sustained absorption rather than the rapid clearance seen with IV. You're getting the finished molecule, absorbed efficiently, at home.

The pharmacokinetic advantage of subcutaneous injection is sustained absorption. Unlike IV infusion, which floods the bloodstream all at once (leading to rapid renal clearance), subcutaneous delivery provides a slower, steadier release into circulation. This means more of the NAD+ you inject actually reaches your cells rather than being excreted. It's the middle ground between convenience and bioavailability.

NAD+ injectable is a compounded medication, prepared by licensed compounding pharmacies based on a provider's prescription. It requires refrigeration to maintain potency. PeRx ships it fully reconstituted and ready to use. Typical protocols call for a small subcutaneous injection once daily, five days per week.

What NAD+ Can Do For You

Cellular energy and fatigue reduction

The most commonly reported benefit, and the most mechanistically supported. NAD+ is literally required for mitochondrial ATP production. When NAD+ levels are depleted, mitochondrial efficiency drops and cells produce less energy. Restoring NAD+ levels can improve mitochondrial function and energy output. Many users report reduced fatigue and increased vitality within the first few weeks of consistent NAD+ therapy. The effect is particularly noticeable in energy-demanding tissues: brain, heart, and skeletal muscle.

Cognitive clarity and brain fog

The brain is one of the most metabolically active organs in the body, consuming roughly 20% of the body's energy despite being only 2% of body weight. It is heavily NAD+-dependent. Age-related NAD+ decline in the brain is associated with cognitive changes including reduced focus, slower processing, and the subjective experience of "brain fog." NAD+ therapy is widely reported to improve mental clarity, though rigorous clinical data on cognitive endpoints is still limited.

DNA repair and anti-aging

This is where the Sinclair framework is most relevant. Sirtuins need NAD+ to function. When NAD+ is depleted, sirtuin activity declines, DNA damage accumulates, and cellular function deteriorates. That's the molecular signature of aging. Restoring NAD+ levels restores sirtuin fuel, theoretically reactivating repair and maintenance pathways that have been starved. In mouse models, NAD+ restoration has reversed age-related physiological decline. Whether this translates to meaningful anti-aging effects in humans remains the central question of the field.

Metabolic health and insulin sensitivity

NAD+ plays a direct role in metabolic regulation through its interaction with SIRT1, SIRT3, and other metabolic enzymes. Restoring NAD+ levels has been associated with improved insulin sensitivity, enhanced fatty acid oxidation, and better glucose metabolism in preclinical models. For people with metabolic syndrome or age-related metabolic decline, NAD+ therapy may support metabolic flexibility, the body's ability to efficiently switch between fuel sources.

Circadian rhythm regulation

NAD+ is intimately connected to your internal clock. Research by Shin Imai and colleagues demonstrated that NAD+ levels oscillate on a circadian cycle and that disrupting this oscillation disrupts sleep-wake patterns. SIRT1 uses NAD+ to regulate circadian gene expression. Sinclair has noted that taking NAD+ precursors in the morning can help reset circadian rhythms, particularly after travel. Many NAD+ therapy users report improved sleep quality as one of the earlier noticeable benefits.

Recovery and exercise performance

NAD+ is essential for exercise metabolism. High-intensity exercise consumes NAD+ while simultaneously stimulating its production. As you age and your NAD+ production capacity declines, exercise recovery takes longer and performance plateaus occur sooner. NAD+ restoration may help close this gap, supporting faster recovery and sustained athletic performance. Sinclair's lab has shown that NMN supplementation in mice mimics some effects of exercise and improves vascular function.

NMN (nicotinamide mononucleotide) is a direct precursor to NAD+. Your body naturally converts NMN into NAD+ in a single enzymatic step, so NMN supplementation is one of the most studied ways to raise NAD+ levels. This figure shows five outcomes from the same clinical trial. Panel A is the headline: all three NMN dose groups showed statistically significant increases in blood NAD+ levels at both 30 and 60 days, while the placebo group stayed flat. This confirms that boosting NAD+ in living humans produces measurable results. Panel B shows improved walking endurance. Panel C shows reduced biological age. Panel D shows improved insulin sensitivity. Panel E shows better self-reported quality of life. The 600 mg and 900 mg doses generally outperformed the 300 mg dose. This was a randomized, double-blind, placebo-controlled trial with 80 participants, the gold standard study design.

Figure 2: Efficacy of placebo vs. 300/600/900 mg NMN groups on blood NAD+ concentration (A), 6-minute walking distance (B), blood biological age (C), HOMA-IR (D), and SF-36 quality of life (E) at day 30 and 60.

Yi L et al. (2023) The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience 45:29-43. · CC BY 4.0

Click image to zoom

NAD+ in the PeRx Peptide Ecosystem

NAD+ occupies the cellular energy and repair layer of a comprehensive wellness protocol. While CJC-1295/Ipamorelin and Sermorelin optimize the growth hormone axis, and BPC-157 and TB-500 drive tissue repair, NAD+ works at a more fundamental level. It fuels the mitochondrial and sirtuin systems that every other biological process depends on. Think of it as the foundation that makes everything else work more efficiently.

The Honest Truth

NAD+ science is strong. Direct NAD+ delivery evidence is growing.

This distinction matters, and most sources blur it. There is a large and growing body of research on NAD+ itself: its role in aging, its decline with age, its relationship to sirtuins and DNA repair, and the effects of restoring it in animal models. This research is published in top-tier journals and represents serious science. Separately, there is solid human data on NAD+ precursors (NMN and NR) showing that supplementation can raise blood NAD+ levels in humans, with some studies showing improvements in physical performance, sleep, and metabolic markers.

Subcutaneous NAD+ injection is pharmacologically well-supported. Subcutaneous delivery is a well-established route for peptides and biologics, providing high bioavailability with sustained absorption. Most of the clinical data on direct NAD+ delivery comes from IV administration, which provides 100% bioavailability but with rapid renal clearance. Subcutaneous injection offers a practical middle ground: high bioavailability, slower and more sustained absorption, and the convenience of at-home administration. Clinical experience with subcutaneous NAD+ is growing, though large-scale randomized trials specific to this delivery method are still needed.

You're probably not going to "never age"

Hailey Bieber's quote is memorable, but it's a joke, not a medical claim. NAD+ therapy, in any delivery form, does not stop aging. What the science suggests is that restoring NAD+ levels may slow certain aspects of cellular decline, improve energy and repair capacity, and support healthier aging. This is meaningful and worth pursuing. But the gap between "may support healthier aging" and "never going to age" is the distance between science and marketing. Manage your expectations accordingly.

The scientific debate is real

Not everyone in the scientific community agrees on NAD+'s therapeutic potential. Sinclair's claims about sirtuins and resveratrol have been publicly challenged by other researchers, including Charles Brenner, who has argued that some of the sirtuin activation data was based on flawed assays. GSK spent billions trying to develop sirtuin-activating drugs and failed. Resveratrol's benefits remain debated. The NAD+ precursor field is complicated by the fact that the key researchers (Sinclair with NMN, Brenner with NR) both have financial ties to competing supplement companies.

This doesn't invalidate the science, but it means you should approach it with appropriate skepticism rather than uncritical enthusiasm. The most honest summary: NAD+'s role in cellular biology is well-established. The therapeutic potential of NAD+ restoration is promising but not proven at the level that would constitute medical certainty. Subcutaneous NAD+ injection is a well-supported delivery mechanism with growing clinical experience.

Keep in Perspective

NAD+ injectable is a compounded medication, not FDA-approved. It's not reviewed by the FDA for safety or effectiveness. If you're interested in NAD+ therapy, work with a licensed healthcare provider who can evaluate whether it's appropriate for your situation and prescribe it safely. And remember: no supplement replaces the lifestyle fundamentals that remain the most evidence-supported tools for healthy aging. Consistent exercise, quality sleep, good nutrition, and stress management do more for longevity than any molecule in a bottle. NAD+ therapy may complement those foundations, but it doesn't substitute for them.

NAD+ Delivery Methods Compared

One molecule, multiple delivery options. Each has its strengths. The right choice depends on your goals, budget, and how depleted your NAD+ levels are.

 NAD+ InjectionNAD+ IV Therapy
What You GetDirect NAD+ moleculeDirect NAD+ molecule
BioavailabilityHigh (subcutaneous absorption, sustained release)100% (direct to bloodstream, rapid clearance)
Cost~$229/month$500-1,500/session
ConvenienceSelf-inject at home, takes minutesClinic visit, 2-4 hours per session
AbsorptionSustained, steady releaseRapid bolus, significant renal excretion
Human EvidenceGrowing (subcutaneous peptide delivery well-established)Moderate (case reports, small studies)
Best ForDaily maintenance, sustained cellular supportAcute restoration, severely depleted NAD+
PrescriptionYes (compounded)Yes (clinical)

For most people, subcutaneous injection is the practical choice: daily use at home, at a fraction of the IV cost, with sustained absorption. Both methods deliver the same molecule. IV gets 100% into your bloodstream all at once, but a significant portion is rapidly excreted. Subcutaneous injection provides a slower, steadier release that may actually deliver more usable NAD+ to your cells over time.

Dosage and Protocols

NAD+ Injection Protocol

Typical Dose

Per provider protocol

Frequency

Once daily, Mon-Fri (5 on / 2 off)

Timing

Morning preferred (circadian support)

Duration

Ongoing daily use (not cycled)

Storage

Refrigerated 36-46°F

Vial Size

100 mg/mL, 10 mL vial

NAD+ injection is designed for consistent daily use, not cycling. Unlike growth hormone peptides that benefit from periodic breaks, NAD+ levels need continuous support because the decline is ongoing. Morning administration is preferred by most clinicians, as NAD+ plays a direct role in circadian rhythm regulation. Taking it in the morning aligns with the body's natural NAD+ oscillation and may support daytime energy without disrupting sleep. Sinclair has noted that taking NAD+ precursors late at night can disrupt circadian rhythms.

The injection is subcutaneous, meaning it goes into the fatty tissue just beneath the skin. Common injection sites include the abdomen (at least 2 inches from the navel), upper thigh, or back of the upper arm. Rotate sites with each injection to avoid irritation. PeRx ships your NAD+ vial fully reconstituted and ready to use, along with detailed dosing instructions.

Some clinicians recommend starting with a lower dose for the first week to assess tolerance before moving to the full daily protocol. People who are also taking oral NMN or NR supplements can continue those alongside the injection. The approaches complement each other through different delivery pathways.

Frequently Asked Questions

Your order arrives via FedEx Overnight in refrigerated packaging with a thick ice block to maintain temperature during transit. PeRx ships NAD+ fully reconstituted and ready to use. Store refrigerated at 36-46 degrees Fahrenheit (2-8 degrees Celsius) to maintain potency. Do not freeze. Keep the vial upright and away from direct light.
NAD+ IV therapy provides 100% bioavailability but costs $500-1,500 per session, requires 2-4 hours in a clinic, and involves an IV line. Subcutaneous NAD+ injection can be self-administered at home in minutes with high bioavailability and sustained absorption, at a fraction of the IV cost. Many clinicians use IV for initial restoration and subcutaneous injection for ongoing daily maintenance.
NMN (nicotinamide mononucleotide) is a precursor molecule that your body converts into NAD+ through an enzymatic reaction. Think of NMN as a raw ingredient and NAD+ as the finished product. NAD+ injection delivers the finished molecule directly, skipping the conversion step entirely. You may see NMN referenced in NAD+ research because it's one of the most studied ways to raise NAD+ levels in clinical trials.
NAD+ injection is generally well-tolerated. Reported side effects include mild injection site redness, brief headache, temporary flushing, and occasional fatigue in the first few days. These tend to be dose-dependent and temporary. IV NAD+ can cause more pronounced effects including nausea.
Some people report increased energy and mental clarity within days. Others take 2-4 weeks of consistent daily use to notice meaningful changes. The timeline depends on baseline NAD+ depletion, age, and lifestyle factors. Benefits tend to build with sustained daily use rather than appearing as a dramatic single-dose effect.

Ready to get started?

Pharmaceutical-grade NAD+ injectable, delivered to your door with everything you need.

View NAD+

Medical Disclaimer

The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.

The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.

The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.

Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.

Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.

© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.

Ready to get started with NAD+?

Pharmaceutical-grade NAD+, prescribed by a licensed provider and shipped to your door.